SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 54.71 |
| Enterprise Value ($M) | 49.17 |
| Book Value ($M) | 13.89 |
| Book Value / Share | 1.41 |
| Price / Book | 3.94 |
| NCAV ($M) | 0.48 |
| NCAV / Share | 0.05 |
| Price / NCAV | 113.26 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.04 |
| Return on Assets (ROA) | -0.57 |
| Return on Equity (ROE) | -2.10 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.76 |
| Current Ratio | 1.76 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 8.29 |
| Assets | 21.70 |
| Liabilities | 7.80 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.23 |
| Operating Income | -16.63 |
| Net Income | -24.91 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -18.55 |
| Cash from Investing | 0.91 |
| Cash from Financing | 24.49 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Opaleye Management Inc. | 7.60 | 15.38 | |
| 13G/A | ADAR1 Capital Management, LLC | 9.99 | 13.42 | |
| 13G/A | Crutcher Patrick J | 7.00 | ||
| 13G/A | Sabby Management, Llc | 0.20 | -90.39 | |
| 13G | Ikarian Capital, LLC | 6.60 | ||
| 13G | ADAR1 Partners, LP | 9.27 | ||
| 13G | Lynx1 Capital Management LP | 9.99 | ||
| 13G/A | Vanguard Group Inc | 0.23 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 61,718 | 239,110 | 25.81 | |
| 152,117 | 360,970 | 42.14 | |
| 121,368 | 625,711 | 19.40 | |
| 81,695 | 363,196 | 22.49 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| HOOK – HOOKIPA Pharma Inc. | HOTH – Hoth Therapeutics, Inc. |
| HRTX – Heron Therapeutics, Inc. | ICCC – ImmuCell Corporation |
| IKT – Inhibikase Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io